Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Vildagliptin + Metformin
Eucreas
Not routinely available
SMC (477/08)
29/03/2023
Indication
Type 2 diabetes. See link to SMC advice for full details of restriction.
Therapeutic Area
Endocrine system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
50mg/850mg, 50mg/1000mg film coated tablets
Comments
-
Link to Advice
Advice Published
07/07/2008
SMC Submission Type
Abbreviated
SMC Status
Restricted